News
-
New guidance document Import of a human medicinal product according to Art. 14 para. 2 and 3 of the Therapeutic Products Act (parallel import)
-
Implementation of the European Pharmacopoeia Supplement 11.3
-
Extension of tariff agreements for pharmacist services and neuropsychology
-
For more transparency in data management in the healthcare sector
-
Revision of the Therapeutic Product Act enhances medication safety
-
Promotion of generics and price reduction for medicinal products
-
Global regulators strengthen efforts to ensure continuous availability of safe and high-quality medicines
-
First version of the Union list of critical medicines agreed to help avoid potential shortages in the European Union
-
Decision C-2105/2022 of 29 November 2023
-
The government includes preventive measures against breast and ovarian cancer in the basic health insurance benefits catalog
-
The majority of the Swiss population is satisfied with healthcare
-
European Union medicines agencies reflect on lessons learned from COVID-19
-
Swissmedic Journal 11/2023
-
Revision of the Epidemics Act for better management of future health crises
-
Covid-19: The federal government covers the costs of vaccination until mid-2024
-
Information system for notifiable diseases becomes more efficient
-
Federal Council adopts vaccine strategy for crisis periods
-
Warning about imports of melatonin and the adrenal hormone dehydroepiandrosterone (DHEA) by private individuals
-
Swissmedic Vigilance-News Edition 31 – November 2023
-
The Federal Government will continue measures against female genital mutilation
-
More efficient assistance in reducing debts for minors and other insured individuals